1.) To understand the background of linking gene expression to survival in order to identify new prognostic biomarkers.
2) To understand a web-tool enabling to ling mutation to survival,
3) To get an overview of available datasets including tissue type (normal/cancer), tissue of tumor origin (breast/ovarian/lung/etc), and data type (DNA/mRNA/miRNA
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation